Steven J. Romano

2.1k total citations · 2 hit papers
32 papers, 1.6k citations indexed

About

Steven J. Romano is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Steven J. Romano has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 10 papers in Clinical Psychology and 6 papers in Pharmacology. Recurrent topics in Steven J. Romano's work include Schizophrenia research and treatment (13 papers), Obsessive-Compulsive Spectrum Disorders (6 papers) and Treatment of Major Depression (6 papers). Steven J. Romano is often cited by papers focused on Schizophrenia research and treatment (13 papers), Obsessive-Compulsive Spectrum Disorders (6 papers) and Treatment of Major Depression (6 papers). Steven J. Romano collaborates with scholars based in United States, Canada and Australia. Steven J. Romano's co-authors include Cynthia Siu, George M. Simpson, Peter J. Weiden, Antony Loebel, Katherine A. Halmi, Suzanne R. Sunday, Philip D. Harvey, R. Tepner, John H. Heiligenstein and Jimmie C. Holland and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Psychopharmacology.

In The Last Decade

Steven J. Romano

32 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

2024 49 citations Steven E. Nissen, Qiuqing Wang et al. JAMA profile →
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)

2024 43 citations Steven E. Nissen, Kathy Wolski et al. JAMA profile →

Peers

Countries citing papers authored by Steven J. Romano

Since Specialization

Citations

This map shows the geographic impact of Steven J. Romano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Romano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Romano more than expected).

Fields of papers citing papers by Steven J. Romano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Romano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Romano. The network helps show where Steven J. Romano may publish in the future.

Co-authorship network of co-authors of Steven J. Romano

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Romano. A scholar is included among the top collaborators of Steven J. Romano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Romano. Steven J. Romano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a) breakdown → 2024 ·JAMA ·Steven E. Nissen, Kathy Wolski, Gerald F. Watts, Michael J. Koren, Henry Fok, Stephen J. Nicholls, David A. Rider, Leslie Cho, Steven J. Romano, (unknown), Curtis Rambaran	43
2	Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a) breakdown → 2024 ·JAMA ·Steven E. Nissen, Qiuqing Wang, Stephen J. Nicholls, Ann Marie Návar, Kausik K. Ray, Gregory G. Schwartz, Michael Szarek, (unknown), Roland P.T. Troquay, Jannick A N Dorresteijn, Henry Fok, David A. Rider, Steven J. Romano, Kathy Wolski, Curtis Rambaran	49
3	Communication About Results Of Comparative Effectiveness Studies: A Pharmaceutical Industry View 2012 ·Health Affairs ·Eleanor M. Perfetto, (unknown), (unknown), Steven J. Romano, Norman Rosenthal, Richard J. Willke	5
4	Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission 2009 ·Journal of Psychiatric Research ·Terence A. Ketter, Ofer Agid, Shitij Kapur, Antony Loebel, Cynthia Siu, Steven J. Romano	23
5	Efficacy and Tolerability of Adjunctive Ziprasidone in Treatment-Resistant Depression 2007 ·The Journal of Clinical Psychiatry ·David L. Dünner, Jay D. Amsterdam, Richard C. Shelton, Antony Loebel, Steven J. Romano	56
6	Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia 2005 ·American Journal of Psychiatry ·George M. Simpson, Peter J. Weiden, (unknown), Stephen A. Murray, Cynthia Siu, Steven J. Romano	62
7	Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder 2004 ·Psychopharmacology ·Philip D. Harvey, Cynthia Siu, Steven J. Romano	66
8	Improvement in Prosocial Functioning After a Switch to Ziprasidone Treatment 2004 ·CNS Spectrums ·Antony Loebel, Cynthia Siu, Steven J. Romano	16
9	Efficacy and Tolerability of Ziprasidone Versus Risperidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder 2004 ·The Journal of Clinical Psychiatry ·Donald Addington, Christos Pantelis, (unknown), I. Benattia, Steven J. Romano	66
10	Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia 2003 ·Schizophrenia Research ·Philip D. Harvey, Herbert Y. Meltzer, George M. Simpson, Steven G. Potkin, Antony Loebel, Cynthia Siu, Steven J. Romano	74
11	Improvement In Indices Of Health Status In Outpatients With Schizophrenia Switched To Ziprasidone 2003 ·Journal of Clinical Psychopharmacology ·Peter J. Weiden, David G. Daniel, George M. Simpson, Steven J. Romano	96
12	A Placebo-Controlled Study of Fluoxetine in Continued Treatment of Bulimia Nervosa After Successful Acute Fluoxetine Treatment 2002 ·American Journal of Psychiatry ·Steven J. Romano, Katherine A. Halmi, Neena Sarkar, Stephanie C. Koke, Julia S. Lee	101
13	Long-Term Treatment of Obsessive-Compulsive Disorder After an Acute Response: A Comparison of Fluoxetine Versus Placebo 2001 ·Journal of Clinical Psychopharmacology ·Steven J. Romano, Wayne K. Goodman, Roy Tamura, Jill Gonzales	61
14	The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder 2001 ·BJOG An International Journal of Obstetrics & Gynaecology ·Meir Steiner, Steven J. Romano, (unknown), (unknown), (unknown), Charlene Berger, Diana Carter, Robert L. Reid, Donna E. Stewart, Susanne Steinberg, Rajinder Judge	46
15	The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder 2001 ·British Journal of Obstetrics and Gynaecology ·Meir Steiner, Steven J. Romano, (unknown), (unknown), (unknown), Charlene Berger, Diana Carter, Robert L. Reid, Donna E. Stewart, Susanne Steinberg, Rajinder Judge	20
16	The role of fluoxetine in the treatment of premenstrual dysphoric disorder 1999 ·Clinical Therapeutics ·Steven J. Romano, Rajinder Judge, (unknown), (unknown), Karen Sundell	20
17	Changes in Insomnia During the Treatment of Depression: An Analysis of Double-Blind, Placebo-Controlled Trials of Fluoxetine Hydrochloride 1999 ·Psychiatric Annals ·Steven J. Romano, R. Tepner, Bruce R. Basson	4
18	A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer 1998 ·Psycho-Oncology ·Jimmie C. Holland, Steven J. Romano, John H. Heiligenstein, R. Tepner, Michael G. Wilson	126
19	The Yale-Brown-Cornell eating disorder scale: Development, use, reliability and validity 1994 ·Journal of Psychiatric Research ·(unknown), Katherine A. Halmi, Suzanne R. Sunday, Steven J. Romano, (unknown)	175
20	Childhood experience and adult depression: A review of studies 1993 ·The American Journal of Psychoanalysis ·Jules R. Bemporad, Steven J. Romano	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact